Ligand and Linkage Isomers of Bis(ethylthiocarbamato) Copper Complexes with Cyclic C 6 H 8 Backbone Substituents: Synthesis, Characterization, and Antiproliferation Activity
Ligand and Linkage Isomers of Bis(ethylthiocarbamato) Copper Complexes with Cyclic C 6 H 8 Backbone Substituents: Synthesis, Characterization, and Antiproliferation Activity
复制标题
具有环状 C 6 H 8 主链取代基的双(乙基硫代氨基甲酸酯)铜配合物的配体和连接异构体:合成、表征和抗增殖活性
DOI:
10.1002/ejic.202300447
复制
发表时间:
2023
影响因子:
2.3
通讯作者:
Grapperhaus, Craig A.
中科院分区:
文献类型:
--
作者:
Bajaj, Kritika;Andres, Sarah A.;Hofsommer, Dillon T.;Chekwube Michael, Okolocha;Mashuta, Mark S.;Bates, Paula J.;Buchanan, Robert M.;Grapperhaus, Craig A.
A series of isomeric bis(alkylthiocarbamate) copper complexes have been synthesized, characterized, and evaluated for antiproliferation activity. The complexes were derived from ligand isomers with 3‐methylpentyl (H2L2) and cyclohexyl (H2L3) backbone substituents, which each yield a pair of linkage isomers. The thermodynamic products CuL2a/3ahave two imino N and two S donors resulting in three five‐member chelate rings (555 isomers). The kinetic isomers CuL2b/3bhave one imino and one hydrazino N donor and two S donors resulting in four‐, six‐, and five‐member rings (465 isomers). The 555 isomers have more accessible CuII/Ipotentials (E1/2=−811/−768 mV vs. ferrocenium/ferrocene) and lower energy charge transfer bands than their 465 counterparts (E1/2=−923/‐854 mV). Antiproliferation activities were evaluated against the lung adenocarcinoma cell line (A549) and nonmalignant lung fibroblast cell line (IMR‐90) using the MTT assay. CuL2awas potent (A549EC50=0.080 μM) and selective (IMR‐90EC50/A549EC50=25) for A549. Its linkage isomer CuL2bhad equivalent A549 activity, but lower selectivity (IMR‐90EC50/A549EC50=12.5). The isomers CuL3aand CuL3bwere less potent withA549EC50values of 1.9 and 0.19 M and less selective withIMR‐90EC50/A549EC50ratios of 2.3 and 2.65, respectively. There was no correlation between reduction potential and A549 antiproliferation activity/selectivity.